These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 37615117)

  • 1. The Multifunction Role of Tumor-Associated Mesenchymal Stem Cells and Their Interaction with Immune Cells in Breast Cancer.
    Chauhan A; Agarwal S; Masih M; Gautam PK
    Immunol Invest; 2023 Nov; 52(7):856-878. PubMed ID: 37615117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative immunomodulatory properties of mesenchymal stem cells derived from human breast tumor and normal breast adipose tissue.
    Sineh Sepehr K; Razavi A; Hassan ZM; Fazel A; Abdollahpour-Alitappeh M; Mossahebi-Mohammadi M; Yekaninejad MS; Farhadihosseinabadi B; Hashemi SM
    Cancer Immunol Immunother; 2020 Sep; 69(9):1841-1854. PubMed ID: 32350594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice.
    Stamatopoulos A; Stamatopoulos T; Gamie Z; Kenanidis E; Ribeiro RDC; Rankin KS; Gerrand C; Dalgarno K; Tsiridis E
    J Bone Oncol; 2019 Jun; 16():100231. PubMed ID: 30956944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential response of mesenchymal stromal cells (MSCs) to type 1 ex vivo cytokine priming: implications for MSC therapy.
    Burnham AJ; Foppiani EM; Goss KL; Jang-Milligan F; Kamalakar A; Bradley H; Goudy SL; Trochez CM; Dominici M; Daley-Bauer L; Gibson G; Horwitz EM
    Cytotherapy; 2023 Dec; 25(12):1277-1284. PubMed ID: 37815775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoma-Associated Mesenchymal Stem/Stromal Cells: Architects of the Pro-tumorigenic Tumor Microenvironment.
    Frisbie L; Buckanovich RJ; Coffman L
    Stem Cells; 2022 Aug; 40(8):705-715. PubMed ID: 35583414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Immunomodulatory Properties of the Human Amnion-Derived Mesenchymal Stromal/Stem Cells Are Induced by INF-γ Produced by Activated Lymphomonocytes and Are Mediated by Cell-To-Cell Contact and Soluble Factors.
    Bulati M; Miceli V; Gallo A; Amico G; Carcione C; Pampalone M; Conaldi PG
    Front Immunol; 2020; 11():54. PubMed ID: 32117234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-associated mesenchymal stem/stromal cells: role in progression and potential targets for therapeutic approaches.
    Hazrati A; Malekpour K; Mirsanei Z; Khosrojerdi A; Rahmani-Kukia N; Heidari N; Abbasi A; Soudi S
    Front Immunol; 2023; 14():1280601. PubMed ID: 38022534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
    Yang M; Li J; Gu P; Fan X
    Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preconditioning of murine mesenchymal stem cells synergistically enhanced immunomodulation and osteogenesis.
    Lin T; Pajarinen J; Nabeshima A; Lu L; Nathan K; Jämsen E; Yao Z; Goodman SB
    Stem Cell Res Ther; 2017 Dec; 8(1):277. PubMed ID: 29212557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
    De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
    Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human mesenchymal stromal/stem cells acquire immunostimulatory capacity upon cross-talk with natural killer cells and might improve the NK cell function of immunocompromised patients.
    Cui R; Rekasi H; Hepner-Schefczyk M; Fessmann K; Petri RM; Bruderek K; Brandau S; Jäger M; Flohé SB
    Stem Cell Res Ther; 2016 Jul; 7(1):88. PubMed ID: 27388156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
    Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
    Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential surrogate quantitative immunomodulatory potency assay for monitoring human umbilical cord-derived mesenchymal stem cells production.
    Teng SW; Sung HY; Wen YC; Chen SY; Lovel R; Chang WY; Wu TB; Hsuan YC; Lin W
    Cell Biol Int; 2021 May; 45(5):1072-1081. PubMed ID: 33470478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory licensed equine MSCs are chondroprotective and exhibit enhanced immunomodulation in an inflammatory environment.
    Cassano JM; Schnabel LV; Goodale MB; Fortier LA
    Stem Cell Res Ther; 2018 Apr; 9(1):82. PubMed ID: 29615127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cell secretome and regenerative therapy after cancer.
    Zimmerlin L; Park TS; Zambidis ET; Donnenberg VS; Donnenberg AD
    Biochimie; 2013 Dec; 95(12):2235-45. PubMed ID: 23747841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR4/TGF-β1 mediated self-differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and promoted colorectal carcinoma development.
    Tan HX; Xiao ZG; Huang T; Fang ZX; Liu Y; Huang ZC
    Cancer Biol Ther; 2020; 21(3):248-257. PubMed ID: 31818187
    [No Abstract]   [Full Text] [Related]  

  • 17. Mesenchymal Stromal Cells Induce Peculiar Alternatively Activated Macrophages Capable of Dampening Both Innate and Adaptive Immune Responses.
    Chiossone L; Conte R; Spaggiari GM; Serra M; Romei C; Bellora F; Becchetti F; Andaloro A; Moretta L; Bottino C
    Stem Cells; 2016 Jul; 34(7):1909-21. PubMed ID: 27015881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor cells educate mesenchymal stromal cells to release chemoprotective and immunomodulatory factors.
    Le Naour A; Prat M; Thibault B; Mével R; Lemaitre L; Leray H; Joubert MV; Coulson K; Golzio M; Lefevre L; Mery E; Martinez A; Ferron G; Delord JP; Coste A; Couderc B
    J Mol Cell Biol; 2020 Apr; 12(3):202-215. PubMed ID: 31504643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsulated human mesenchymal stem cells (eMSCs) as a novel anti-cancer agent targeting breast cancer stem cells: Development of 3D primed therapeutic MSCs.
    Mandal S; Arfuso F; Sethi G; Dharmarajan A; Warrier S
    Int J Biochem Cell Biol; 2019 May; 110():59-69. PubMed ID: 30735730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory Effect of Human Umbilical Cord Blood-derived Mesenchymal Stem Cells on Activated T-lymphocyte.
    Lotfinejad P; Shamsasenjan K; Baradaran B; Safarzadeh E; Kazemi T; Movassaghpour AA
    Iran J Allergy Asthma Immunol; 2021 Dec; 20(6):711-720. PubMed ID: 34920654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.